Richard Quintiliani

8.9k total citations
260 papers, 6.9k citations indexed

About

Richard Quintiliani is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Richard Quintiliani has authored 260 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 166 papers in Pharmacology, 92 papers in Epidemiology and 81 papers in Molecular Medicine. Recurrent topics in Richard Quintiliani's work include Antibiotics Pharmacokinetics and Efficacy (163 papers), Antibiotic Resistance in Bacteria (81 papers) and Pneumonia and Respiratory Infections (53 papers). Richard Quintiliani is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (163 papers), Antibiotic Resistance in Bacteria (81 papers) and Pneumonia and Respiratory Infections (53 papers). Richard Quintiliani collaborates with scholars based in United States, France and Taiwan. Richard Quintiliani's co-authors include David P. Nicolau, Charles H. Nightingale, C H Nightingale, C H Nightingale, Patrice Courvalin, Collin D. Freeman, Melinda K. Lacy, Paul Belliveau, Jack Ross and Michel Arthur and has published in prestigious journals such as JAMA, Annals of Internal Medicine and PEDIATRICS.

In The Last Decade

Richard Quintiliani

254 papers receiving 6.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Quintiliani United States 42 3.4k 2.6k 1.9k 1.9k 1.0k 260 6.9k
Ethan Rubinstein Canada 45 1.8k 0.5× 2.4k 0.9× 1.8k 0.9× 2.4k 1.3× 877 0.9× 140 6.8k
Stephen H. Zinner United States 44 2.4k 0.7× 1.8k 0.7× 1.9k 1.0× 1.2k 0.6× 1.6k 1.6× 189 6.8k
James J. Rahal United States 42 1.6k 0.5× 2.3k 0.9× 3.1k 1.6× 1.8k 1.0× 813 0.8× 109 6.5k
A L Barry United States 44 2.6k 0.8× 2.8k 1.1× 2.3k 1.2× 3.0k 1.6× 1.4k 1.4× 288 7.3k
Alasdair MacGowan United Kingdom 47 2.8k 0.8× 2.3k 0.9× 2.8k 1.4× 2.2k 1.2× 1.6k 1.6× 284 8.4k
Michael Barza United States 49 2.0k 0.6× 1.5k 0.6× 1.1k 0.6× 1.3k 0.7× 732 0.7× 182 7.6k
David E. Nix United States 39 2.7k 0.8× 2.7k 1.1× 1.4k 0.8× 1.4k 0.7× 564 0.6× 140 5.8k
Paul S. Lietman United States 47 2.5k 0.7× 2.9k 1.1× 837 0.4× 1.5k 0.8× 605 0.6× 161 8.1k
Keith A. Rodvold United States 51 4.9k 1.4× 3.2k 1.2× 2.2k 1.1× 3.7k 2.0× 1.9k 1.9× 186 10.2k
Harold C. Standiford United States 35 1.6k 0.5× 1.2k 0.4× 1.4k 0.8× 1.6k 0.9× 1.2k 1.2× 92 4.5k

Countries citing papers authored by Richard Quintiliani

Since Specialization
Citations

This map shows the geographic impact of Richard Quintiliani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Quintiliani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Quintiliani more than expected).

Fields of papers citing papers by Richard Quintiliani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Quintiliani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Quintiliani. The network helps show where Richard Quintiliani may publish in the future.

Co-authorship network of co-authors of Richard Quintiliani

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Quintiliani. A scholar is included among the top collaborators of Richard Quintiliani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Quintiliani. Richard Quintiliani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bulik, Catharine C., Richard Quintiliani, J. Samuel Pope, Joseph L. Kuti, & David P. Nicolau. (2009). Pharmacodynamics and tolerability of high-dose, prolonged infusion carbapenems in adults with cystic fibrosis – A review of 3 cases. Respiratory Medicine CME. 3(3). 146–149. 13 indexed citations
2.
Nicolau, David P., et al.. (2002). Minimal Interaction between Gatifloxacin and Oxycodone. The Journal of Clinical Pharmacology. 42(8). 928–932. 3 indexed citations
3.
Xuan, Dawei, Mingkang Zhong, Holly M. Mattoes, et al.. (2001). Streptococcus pneumoniae Response to Repeated Moxifloxacin or Levofloxacin Exposure in a Rabbit Tissue Cage Model. Antimicrobial Agents and Chemotherapy. 45(3). 794–799. 21 indexed citations
4.
Ambrose, Paul G., et al.. (2000). Clinical efficacy of cefepime in pneumonia caused by Pseudomonas aeruginosa. 40. 494. 3 indexed citations
5.
Lacy, Melinda K., David P. Nicolau, Mary Anné Banevicius, Charles H. Nightingale, & Richard Quintiliani. (1999). Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniaein a murine sepsis model. Journal of Antimicrobial Chemotherapy. 44(4). 477–481. 6 indexed citations
6.
Nightingale, C H, et al.. (1995). Comparison of the Pharmacodynamic Activity of Cefotaxime plus Metronidazole With Cefoxitin and Ampicillin plus Sulbactam. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(4). 479–486. 4 indexed citations
7.
Patel, Kalpana B., David P. Nicolau, Charles H. Nightingale, & Richard Quintiliani. (1995). Pharmacokinetics of cefotaxime in healthy volunteers and patients. Diagnostic Microbiology and Infectious Disease. 22(1-2). 49–55. 29 indexed citations
8.
Freeman, Collin D., C H Nightingale, & Richard Quintiliani. (1994). Minocycline: old and new therapeutic uses. International Journal of Antimicrobial Agents. 4(4). 325–335. 14 indexed citations
9.
Freeman, Collin D., Richard Quintiliani, & Charles H. Nightingale. (1993). Vancomycin Therapeutic Drug Monitoring. Annals of Pharmacotherapy. 27(5). 594–598. 78 indexed citations
10.
Nicolau, David P., et al.. (1992). Once-daily aminoglycosides.. PubMed. 56(10). 561–3. 18 indexed citations
11.
Quercia, Robert, et al.. (1991). Strategy for developing a safe and cost-effective H2-receptor antagonist program.. PubMed. 26 Suppl D. 20–4. 1 indexed citations
12.
Quintiliani, Richard, et al.. (1988). Comparative pharmacokinetics of cefotetan and cefoxitin in patients undergoing hysterectomies and colorectal operations. The American Journal of Surgery. 155(5). 67–70. 7 indexed citations
13.
Tsuji, Ai, et al.. (1984). THE EFFECT OF PROTEIN-BINDING ON DRUG DISTRIBUTION INTO INTERSTITIAL FLUID (IF). Clinical Pharmacology & Therapeutics. 35(2). 275. 2 indexed citations
14.
Shyu, Wen Chyi, C H Nightingale, Richard Quintiliani, & Karen S. Oles. (1981). Stability of Cephalosporins in Commercial Sera. The Journal of Infectious Diseases. 144(5). 483–483.
15.
Klimek, Joseph J., et al.. (1980). Penetration characteristics of trimethoprim-sulfamethoxazole in middle ear fluid of patients with chronic serous otitis media. The Journal of Pediatrics. 96(6). 1087–1089. 17 indexed citations
16.
Weir, Bryce, et al.. (1977). Safety and efficacy of combining obstetric and noninfectious gynecologic hospital patients.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 50(4). 431–4. 1 indexed citations
17.
Weinstein, Melvin, et al.. (1975). Further observations on the antimicrobial effects of local anesthetic agents.. PubMed. 17(4). 369–74. 26 indexed citations
18.
Quintiliani, Richard, et al.. (1973). Clinical Experience on the Detection of Endotoxemia with the Limulus Test. The Journal of Infectious Diseases. 127(1). 102–105. 42 indexed citations
19.
Quintiliani, Richard. (1973). Current Concepts in Therapy. Southern Medical Journal. 66(8). 940–947. 1 indexed citations
20.
Quintiliani, Richard. (1971). Polymyxin B in the Treatment of Klebsiella pneumoniae Meningoventriculitis. American journal of diseases of children. 121(3). 239–239. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ethan Rubinstein Breakdown of academic impact, for papers by Stephen H. Zinner Breakdown of academic impact, for papers by James J. Rahal Breakdown of academic impact, for papers by A L Barry Breakdown of academic impact, for papers by Alasdair MacGowan Breakdown of academic impact, for papers by Michael Barza Breakdown of academic impact, for papers by David E. Nix Breakdown of academic impact, for papers by Paul S. Lietman Breakdown of academic impact, for papers by Keith A. Rodvold Breakdown of academic impact, for papers by Harold C. Standiford
Rankless by CCL
2026